Mayo, vendor develop patient blood management solution

Mayo Medical Laboratories and National Decision Support Company have jointly developed a new patient blood management solution.

Called CareSelect Blood, the solution is based on best practices from a patient blood-management program implemented in 2010 at the Mayo Clinic’s Rochester campus that subsequently resulted in a 35 percent reduction in blood transfusions, improved patient outcomes and cost savings.

By leveraging Mayo’s clinical knowledge and NDSC’s expertise in electronic health record clinical-decision support, executives from both organizations contend that the platform can help providers establish the appropriate utilization of blood products.

“The problem is this—too many transfusions, too much waste and an increased probability of adverse outcomes,” says Michael Mardini, CEO of NDSC. “By expanding our relationship with Mayo Medical Laboratories, we’re able to reduce variation of care, provide reliable standards and report data needed to improve performance. This can lead to improved population health, increased provider efficiency and lower cost of care.”

With data available from more than 740,000 individual transfusion events, CareSelect Blood features 100 curated transfusion guidelines—authored and maintained by Mayo—that can be integrated into a provider organization’s EHR within the physician workflow to ensure proper ordering.

mayo.png

Also See: Analytics aid healthcare systems in cutting unnecessary blood use

“With blood being a finite and expensive resource, we need to practice proper stewardship to prevent overuse,” says Daryl Kor, MD, an anesthesiologist and medical director of patient blood management at Mayo Clinic. “Current studies indicate that 40 to 60 percent of transfusions are deemed unnecessary or avoidable.”

According to Kor, CareSelect Blood also offers consulting services to health systems.

“We have subject matter experts who will visit the healthcare organization to provide on-site training, review analytics and reports, and discuss the evidence-based transfusion guidelines,” adds Kor. “This program can be customized to a hospital’s specific needs and tailored to various personas within an organization—for example, surgery, nursing or the laboratory.”

Mayo has a financial interest in CareSelect Blood, noting that any revenue it receives will be used to support its not-for-profit mission in patient care, education and research.

For reprint and licensing requests for this article, click here.